Skip to main content

eXp World Holdings Reports Q1 2026 Results

eXp World Holdings Reports Q1 2026 ResultseXp World Holdings Reports Q1 2026 ResultsBELLINGHAM, Wash., May 11, 2026 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: AGNT) (the “Company,” “eXp” or “we”), the holding company for eXp Realty®, NextHome, Inc., FrameVR.io and SUCCESS® Enterprises, today announced financial results for the first quarter 2026 ended March 31, 2026. “Our first quarter results exceeded our revenue expectations as agent productivity continues to increase,” said Leo Pareja, CEO of eXp Realty. “We have always been a company built by agents, built for agents, and this quarter we’ve taken a meaningful step in broadening that mission. The addition of NextHome creates maximum optionality across our platform. This multi-model approach serves the full spectrum of real estate entrepreneurs on a single,...

Continue reading

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time WALTHAM, Mass., May 11, 2026 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today announced the launch of a new programmatic connection point between OptimizeRx’s proprietary EHR network and DSPs, enabling media buyers to activate scalable, point of care campaigns within their existing programmatic workflows. This launch also opens up new access for OptimizeRx to the programmatic market, estimated at 90% of the total U.S. digital display ad spend across all industries. Bridging...

Continue reading

Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates

Presented positive Phase 3 HAELO topline clinical data for lonvo-z in HAE; initiated rolling BLA submission; anticipate U.S. launch in first half of 2027 Recently resumed patient screening in MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nex-z in ATTR-CM and ATTRv-PN, respectively Including proceeds from underwritten public offering in April, existing cash resources expected to fund operations at least into 2028CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today reported business updates and financial results for the first quarter ended March 31, 2026. “It has been a remarkable start to 2026 for Intellia,” said John Leonard, M.D., Intellia President...

Continue reading

Cronos Group Reports 2026 First Quarter Results

Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS® continues to be the number one cannabis brand2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2026 first quarter business results. “Cronos delivered record net revenue and gross profit in the first quarter, as we continue to execute against our borderless products strategy and as additional supply from the expansion at Cronos GrowCo fuels our next phase of growth. Cronos Israel delivered another record quarter,...

Continue reading

Beneficient Statement on Heppner Conviction

DALLAS, May 11, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today issued a statement regarding the conviction of the Company’s former Chairman and CEO, Brad Heppner, by a federal jury in the United States District Court for the Southern District of New York (“SNDY”) on charges of securities fraud, wire fraud, conspiracy to commit securities fraud and wire fraud, and false statements to auditors in connection with a scheme to defraud GWG Holdings, Inc. As established at trial, Mr. Heppner acted solely on behalf of his family office to perpetrate this scheme through a shell company he controlled. See here for SDNY’s press release announcing the verdict. As...

Continue reading

DEEP SEA MINERALS CORP. PARTICIPATES IN THE 2026 OTC CONFERENCE IN HOUSTON, TEXAS

Vancouver, BC, May 11, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company”), a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to recap its participation at the 2026 Offshore Technology Conference (“OTC”), held May 4 – 7, 2026, at the NRG Center in Houston, Texas. Deep Sea Minerals was represented at the conference by James Deckelman, Chief Executive Officer, and Dan McConnell, Vice President of Exploration. Mr. McConnell also serves as Chair of the OTC Board of Directors, reflecting the Company’s continued engagement with the broader offshore technology and marine resources community. OTC 2026 brought together offshore energy, marine technology, government,...

Continue reading

Nightfood Holdings (NGTF) Expands AI-Powered Robotics Platform Through Strategic Partnership with Established National Deployment Provider

Collaboration expected to accelerate Robotics-as-a-Service growth strategy across hospitality, logistics, healthcare, and commercial automation markets LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) — via IBN – Nightfood Holdings, Inc. (OTCQB: NGTF) (“Nightfood” or the “Company”), operating through its TechForce Robotics division, today announced a strategic partnership initiative with ToDo Robotics, an established robotics deployment and integration company that has completed more than 300 robotic system deployments since inception, as Nightfood continues expanding its national AI-powered automation and Robotics-as-a-Service (“RaaS”) platform across high-growth commercial markets. The collaboration is designed to accelerate TechForce Robotics’ commercial expansion strategy by combining the Company’s AI-powered robotics ecosystem, autonomous...

Continue reading

Quantum Leap Energy Enters into Memorandum of Understanding with European Nuclear Technology Company for Advanced Nuclear Fuel Supply Collaboration

MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 DALLAS, May 11, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” “QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has entered into a non-binding Memorandum of Understanding (MOU) with a European nuclear technology company specializing in advanced nuclear reactor development and other next-generation nuclear energy solutions. “Securing reliable HALEU supply is one of the most critical challenges facing the advanced nuclear industry today. This MOU is a meaningful step in QLE’s mission to build...

Continue reading

ROE Dental Laboratory Becomes First U.S. Lab to Deploy an Extensive Fleet of 3D Systems Jetted-Denture Printing Systems Across Multiple Sites

ROE triples its manufacturing capacity for high-precision, multi-material monolithic dentures, capitalizing on early success with the NextDent® 300 jetted-denture solution to meet accelerating U.S. demand. Expansion highlights rapid commercial adoption of 3D Systems’ industry-first multi-material Jetted Denture Solution. Reinforces 3D Systems’ leadership in digital dentistry as labs shift from conventional methods to scalable, high-margin digital workflows.ROCK HILL, S.C., May 11, 2026 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that ROE Dental Laboratory, one of the nation’s premier full-service dental labs, has purchased additional NextDent® 300 3D printers to expand its digital denture manufacturing capacity. With multiple systems in multiple locations now coming online, ROE becomes the leading dental laboratory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.